Tumor stromal nicotinamide N-methyltransferase overexpression as a prognostic biomarker for poor clinical outcome in early-stage colorectal cancer
Open Access
- 17 February 2022
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 12 (1) , 1-12
Abstract
In a quest for prognostic biomarkers in early-stage colorectal cancer, we investigated NNMT (nicotinamide N-methyltransferase) in large cohorts of patients. Immunohistochemical examination of 679 patients illustrates that NNMT protein is predominantly expressed in the cancer stroma at varying levels, and about 20% of cancer tissues overexpress NNMT when compared to levels observed in normal colorectal mucosa. Clinical correlation analyses of 572 patients with early-stage cancers reveal that NNMT protein overexpression is significantly associated with shorter overall and disease-free survival, but no such correlation is found in late-stage colorectal cancer. Analyses of TCGA and CPTAC colorectal cancer cohorts show that NNMT mRNA expression is positively correlated with protein levels, is significantly higher in CIMP-high or MSI subtypes than in CIMP-low or MSS subtypes, and is positively correlated with its paralog INMT but not with its interaction partners such as PNMT, ADK, APP, ATF6, BMF, BRD4, CDC37, or CRYZ. In early-stage cancers, NNMT expression is higher in BRAF-mutated than in BRAF wild type tumors but is not affected by KRAS or PIK3CA mutation status. As a cancer stromal protein with important roles in metabolism and cancer epigenetics, NNMT is emerging as a promising biomarker for risk stratification of early-stage cancers.Keywords
Funding Information
- National Institutes of Health (R21 CA251992)
- Neuroendocrine Tumor Research Foundation
- Farmer Family Foundation
- Cycle for Survival
This publication has 42 references indexed in Scilit:
- NNMT promotes epigenetic remodeling in cancer by creating a metabolic methylation sinkNature Chemical Biology, 2013
- Comprehensive molecular characterization of human colon and rectal cancerNature, 2012
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics DataCancer Discovery, 2012
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivityNature, 2012
- CpG Island Methylator Phenotype-Low (CIMP-Low) in Colorectal Cancer: Possible Associations with Male Sex and KRAS MutationsThe Journal of Molecular Diagnostics, 2006
- Overexpression of nicotinamide N-methyltransferase in gastric cancer tissues and its potential post-translational modificationExperimental & Molecular Medicine, 2006
- Identification of NicotinamideN-Methyltransferase as a Novel Serum Tumor Marker for Colorectal CancerClinical Cancer Research, 2005
- Many paths to methyltransfer: a chronicle of convergenceTrends in Biochemical Sciences, 2003
- Human NicotinamideN-Methyltransferase Gene: Molecular Cloning, Structural Characterization and Chromosomal LocalizationGenomics, 1995
- Fluorometric Assay of Rat Tissue N-Methyltransferases with Nicotinamide and Four Isomeric Methylnicotinamides.Chemical and Pharmaceutical Bulletin, 1992